FOLH1 and prostate cancer: We anticipate the predictive value of TLP is based on its ability to assess molecular imaging characteristics as PSMA expression and volumetric burden of prostate cancer, as it is calculated by the summed products of volume × uptake (SUVmean) of all lesions.